Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07507474

Performance of the Treatment of Periodontitis According to the Bioperio® Protocol

This multicenter, prospective, single-arm observational study evaluated the clinical performance of the Bioperio® protocol, a standardized, patient-centered framework for managing periodontitis. The protocol combined professional supra-gingival scaling, oral hygiene instruction and motivation, full-mouth subgingival instrumentation, and-in Stage III/IV cases-adjunctive enamel matrix derivative application in deep pockets.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of periodontitis (proximal attachment loss in ≥2 non-adjacent teeth)
  • No previous treatment for periodontitis
  • Systemically healthy or with well-controlled chronic medical conditions
  • Willingness to participate in the study and comply with the follow-up schedule

Exclusion criteria

  • Pregnancy or breastfeeding
  • Patients previously treated for periodontitis
  • Poorly controlled systemic conditions
  • Refusal to participate
  • Patients who did not complete the proposed treatment plan

Treatment and study plan

Periodontal non surgical treatment

Procedure

Non surgical periodontal therapy performed with ultrasonics and manual instruments. In patients affected by stages III-IV periodontitis, the adjunctive usage of wound healing enhancers will be applied in sites with PPD >5 mm.

Other names: Scaling and root planing

Oral Hygiene Instructions

Behavioral

Patients will be motivated and instructed to improve their daily home dental plaque control through the usage of interdental devices and electric toothbrush.

Surgical Periodontal Treatment

Procedure

In some selected patients, whose periodontal defects will not heal despite consecutive non surgical interventions, periodontal surgical treatment, with or without regenerative devices, will be implemented.

Other names: periodontal surgery

Primary outcomes

  1. Pocket Closure

    Time frame: 3 months and subsequent follow-ups

    Percentage of affected sites (probing pocket depth ≥4 mm at baseline) that achieve a probing pocket depth <4 mm

  2. Periodontitis Patient Resolution

    Time frame: 3 months and subsequent follow-ups

    Number and percentage of participants showing no sites with PPD>5 mm at 3 months and subsequent re-evaluation

Secondary outcomes

  1. Change in Probing Pocket Depth (PPD)

    Time frame: 3 months and subsequent follow-ups

    Change in mean PPD from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.

  2. Change in Clinical Attachment Level (CAL)

    Time frame: 3 months and subsequent follow-ups

    Change in mean CAL from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.

  3. Change in Full-Mouth Bleeding Score (FMBS)

    Time frame: 3 months and subsequent follow-ups

    Change in FMBS from baseline to 3 months and subsequent re-evaluation. FMBS is a periodontal index used to assess gingival inflammation by recording the presence or absence of bleeding on probing at multiple sites around all teeth. Common systems include the Ainamo and Bay (1975) method, using a 6-site per tooth recording (mesiobuccal, buccal, distobuccal, distolingual, lingual, mesiolingual).

    The score is calculated as (number of bleeding sites / total number of sites examined) × 100%. So a percentage. Interpretation: low scores (<10% usually healthy), 10-30% mild inflammation, >30% significant inflammation. Clinical significance: high scores indicate poor oral hygiene, active gingivitis, risk for periodontitis progression, need for more frequent recall or scaling/root planing.

  4. Change in Number of Deep Pockets

    Time frame: 3 months and subsequent follow-ups

    Change in the number of sites with PPD ≥5 mm and ≥6 mm from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.

  5. Gingivitis Patient Resolution

    Time frame: 3 months and subsequent follow-ups

    Description: Number of participants achieving a full-mouth bleeding score (FMBS) <10%. FMBS is a periodontal index used to assess gingival inflammation by recording the presence or absence of bleeding on probing at multiple sites around all teeth. Common systems include the Ainamo and Bay (1975) method, using a 6-site per tooth recording (mesiobuccal, buccal, distobuccal, distolingual, lingual, mesiolingual). The score is calculated as (number of bleeding sites / total number of sites examined) × 100%. So a percentage. Interpretation: low scores (<10% usually healthy), 10-30% mild inflammation, >30% significant inflammation. Clinical significance: high scores indicate poor oral hygiene, active gingivitis, risk for periodontitis progression, need for more frequent recall or scaling/root planing.

  6. Psychometric testing and Oral Health Related Quality of Life

    Time frame: 3 months and subsequent follow-ups

    Psychometric outcomes will be evaluated to assess the impact of the intervention on participants' perceived oral health and related quality of life. The Oral Health Impact Profile-14 (OHIP-14) will be administered as a secondary outcome measure at predefined study time points. This validated instrument captures functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap associated with oral conditions. Changes in OHIP-14 scores over time will be analyzed to determine the extent to which the intervention influences oral health-related quality of life.

  7. Capillary blood sampling via finger prick

    Time frame: 3 months and subsequent follow-ups

    Capillary blood samples will be obtained via finger prick to measure C-reactive protein (CRP) and vitamin D levels. The procedure is minimally invasive and will be performed using a sterile, single-use lancet to obtain a small volume of blood. Samples will be analyzed using validated methods to assess inflammatory status (CRP) and vitamin D concentration.

  8. Biologic fluid samples

    Time frame: 3 months and subsequent follow-ups

    Biologic fluid samples, including saliva and peripheral blood, will be collected from study participants to support exploratory and confirmatory analyses.

Study contacts

Contact information is provided by the study sponsor or research team.

Filippo Graziani, Prof.

CONTACT

[email protected]

+393384014984

Sponsors and collaborators

Lead sponsor

University of Pisa

Other

Registry information

Official study title

Performance of the Treatment of Periodontitis According to the Bioperio® Protocol: a Prospective Cohort Study

Acronym: BIOPERIO

Important dates

Study start
2023
Primary completion
2025
Study completion
2030
First posted
Apr 2, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.